Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Change in Taxes (2023 - 2025)

Historic Change in Taxes for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to -$143.0 million.

  • Genmab A's Change in Taxes fell 18600.0% to -$143.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$460.0 million, marking a year-over-year decrease of 36464.65%. This contributed to the annual value of -$460.0 million for FY2025, which is 82000.0% down from last year.
  • Per Genmab A's latest filing, its Change in Taxes stood at -$143.0 million for Q4 2025, which was down 18600.0% from -$2.0 million recorded in Q3 2025.
  • Over the past 5 years, Genmab A's Change in Taxes peaked at -$2.0 million during Q3 2024, and registered a low of -$268.0 million during Q2 2025.
  • Moreover, its 3-year median value for Change in Taxes was -$48.5 million (2024), whereas its average is -$89.2 million.
  • As far as peak fluctuations go, Genmab A's Change in Taxes skyrocketed by 6774.19% in 2024, and later crashed by 18600.0% in 2025.
  • Genmab A's Change in Taxes (Quarter) stood at -$155.0 million in 2023, then skyrocketed by 67.74% to -$50.0 million in 2024, then plummeted by 186.0% to -$143.0 million in 2025.
  • Its last three reported values are -$143.0 million in Q4 2025, -$2.0 million for Q3 2025, and -$268.0 million during Q2 2025.